- Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
- Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
- Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
- Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
- Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
More ▼
Key statistics
On Tuesday, Hims & Hers Health Inc (HIMS:NYQ) closed at 20.83, -2.85% below its 52-week high of 21.44, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.15 |
---|---|
High | 20.87 |
Low | 19.41 |
Bid | 20.75 |
Offer | 20.85 |
Previous close | 20.49 |
Average volume | 15.65m |
---|---|
Shares outstanding | 214.79m |
Free float | 178.55m |
P/E (TTM) | -- |
Market cap | 4.17bn USD |
EPS (TTM) | -0.0145 USD |
Data delayed at least 15 minutes, as of Jun 05 2024 00:00 BST.
More ▼